| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
24,817 |
17,907 |
$2.31M |
| 87428 |
|
2,619 |
2,466 |
$110K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,838 |
12,739 |
$52K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,175 |
3,793 |
$40K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,858 |
3,288 |
$32K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,510 |
2,964 |
$25K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,567 |
2,943 |
$14K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,702 |
2,078 |
$9K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,040 |
622 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,107 |
1,365 |
$785.77 |
| 87807 |
|
63 |
62 |
$660.00 |
| 87430 |
|
653 |
470 |
$522.64 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
226 |
134 |
$300.75 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
149 |
118 |
$264.52 |
| 81003 |
|
145 |
116 |
$18.40 |
| 81025 |
|
16 |
13 |
$2.60 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
278 |
216 |
$1.96 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
49 |
39 |
$1.02 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
95 |
74 |
$0.47 |
| 3078F |
|
135 |
129 |
$0.00 |
| 3079F |
|
15 |
15 |
$0.00 |
| 3074F |
|
200 |
185 |
$0.00 |
| 87084 |
|
30 |
17 |
$0.00 |